DURECT Corp declares sale of 4.44m shares of common stock
DRRX | Quote | Chart | News | PowerRating -- Speciality pharmaceutical company DURECT Corp (Nasdaq:DRRX) declared on
Friday the sale of 4,444,444 primary shares of common stock.
The agreement was executed with affiliates of Venrock, a premier
venture capital firm.
The financing was priced at USD2.25 per share for net proceeds of
approximately USD10m to DURECT.
The financing is expected to be concluded on or about 18 September 2009
subject to customary closing conditions.
Comments on this story may be sent to admin@m2.com
For full details on Durect Corporation (DRRX) DRRX. Durect Corporation (DRRX) has Short Term PowerRatings at TradingMarkets. Details on Durect Corporation (DRRX) Short Term PowerRatings is available at This Link.
- SmarTrend Detects Continued Selling Pressure in Shares of Durect (DRRX) - 02/04/10
- SmarTrend's Candlestick Scanner Detects Bullish Harami Pattern for Durect (DRRX) - 02/01/10
- DURECT Corporation (DRRX) Corporate Event Announcement Notice - 01/26/10
- DURECT Corporation (DRRX) Corporate Event Announcement Notice - 01/25/10
- DRRX: Begins Dosing in Phase III Trial of POSIDUR(TM) for Post-Surgical Pain - 01/19/10
- More News >>


